Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The impact of legislation on future technology development.

P Wilding1

  • 1Hospital of the University of Pennsylvania, Department of Pathology and Laboratory Medicine, Philadelphia 19104.

Clinical Chemistry
|July 1, 1992
PubMed
Summary

This study analyzes factors affecting technology development in clinical chemistry diagnostics. It investigates if the Clinical Laboratory Improvement Amendments of 1988 (CLIA

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salt-induced swelling of meat: The effect of storage time, pH, ion-type and concentration.

Meat science·2011
Same author

Microchip PCR.

Analytical and bioanalytical chemistry·2003
Same author

DOP-PCR amplification of whole genomic DNA and microchip-based capillary electrophoresis.

Methods in molecular biology (Clifton, N.J.)·2001
Same author

Microchip module for blood sample preparation and nucleic acid amplification reactions.

Genome research·2001
Same author

Agilent 2100 bioanalyzer for restriction fragment length polymorphism analysis of the Campylobacter jejuni flagellin gene.

Journal of clinical microbiology·2001
Same author

Evaluation of DNA fragment sizing and quantification by the agilent 2100 bioanalyzer.

Clinical chemistry·2000

Area of Science:

  • Clinical Chemistry
  • Diagnostic Technology Development
  • Health Policy

Background:

  • The clinical chemistry sector faces unique challenges in technology development.
  • Understanding regulatory impacts is crucial for innovation in diagnostics.

Purpose of the Study:

  • To examine factors influencing technology development in clinical chemistry.
  • To assess the impact of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on U.S. diagnostic technology development opportunities and challenges.

Main Methods:

  • Qualitative analysis of regulatory and market factors.
  • Review of historical trends in diagnostic technology.

Main Results:

  • CLIA '88 presents a complex influence on technology development.
  • Specific provisions may create barriers while others foster innovation.

Conclusions:

  • The net effect of CLIA '88 requires nuanced understanding.
  • Policy adjustments could optimize the regulatory environment for diagnostic innovation.

Related Experiment Videos